Chronicle Journal: Finance

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Adicet Bio Inc (NQ: ACET )

15.31 USD -0.44 (-2.79%)
Official Closing Price Updated: 4:56 PM EST, Feb 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 218,370
Open 15.29
Bid (Size) 13.11 (1)
Ask (Size) 15.49 (2)
Prev. Close 15.75
Today's Range 14.77 - 15.85
52wk Range 9.710 - 21.40
Shares Outstanding 30,788,044
Dividend Yield 0.98%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Adicet Bio, Inc. Announces Closing of $152 Million Public Offering and Concurrent Private Placement and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
From GlobeNewswire News Releases
Adicet Bio to Participate in Upcoming Investor Conferences
From GlobeNewswire News Releases

Performance

YTD
+14.08%
+14.08%
1 Month
+17.23%
+17.23%
3 Month
+23.17%
+23.17%
6 Month
-0.58%
-0.58%
1 Year
-0.58%
-0.58%

More News

Read More
Adicet Bio, Inc. Announces Pricing of $135 Million Public Offering of Common Stock and Concurrent Private Placement
From GlobeNewswire News Releases
Adicet Bio, Inc. Announces Proposed Public Offering of Common Stock and Concurrent Private Placement
From GlobeNewswire News Releases
Adicet Bio to Participate in Upcoming Investor Conferences
From GlobeNewswire News Releases
Adicet Bio to Participate in Fireside Chat at JMP Securities Hematology Summit
From GlobeNewswire News Releases
Adicet Announces Appointment of Dr. Bastiano Sanna to its Board of Directors
From GlobeNewswire News Releases
Adicet Bio to Participate in Upcoming Investor Conferences
From GlobeNewswire News Releases
Adicet Reports Third Quarter 2020 Financial Results and Provides Business Update
From GlobeNewswire News Releases
Adicet Appoints Don Healey, Ph.D., as Chief Technology Officer
From GlobeNewswire News Releases
Adicet Announces FDA Clearance of IND Application for First-in-Class Allogeneic CAR Gamma-Delta T Cell Therapy
From GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]